A phase III study of TAK-536 (long-term use study)
Latest Information Update: 24 May 2016
At a glance
- Drugs Azilsartan (Primary)
- Indications Essential hypertension
- Focus Adverse reactions
- Sponsors Takeda
- 24 May 2016 New trial record
Latest Information Update: 24 May 2016